A new mechanism involving CREB3L1 cleavage is proposed to explain doxorubicin's anti-tumour effects.
A new mechanism involving cleavage of a transcription factor called CREB3L1 has been proposed to explain the anti-tumour effects of doxorubicin.
No takes yet. Share an insight, caveat, or question.
Patel et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: